Prospects of perfusion contrast-enhanced ultrasound (CE-US) in diagnosing axillary lymph node metastases in breast cancer: a comparison with lymphatic CE-US
Journal of Medical Ultrasonics · 2024-10 · 51 (4) · 587-597
DOI: 10.1007/s10396-024-01444-w ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Medical Ultrasonics, online erschienen am 20.04.2024. Verfasst von Naoko Mori und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita, Akita, 010-8543, Japan. naokomori7127@gmail.com. Hauptthemen laut MEDLINE: Breast Neoplasms, Contrast Media, Lymphatic Metastasis, Axilla. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Akita University.
Abstract (Originalsprache)
Accurate diagnosis of lymph node (LN) metastasis is vital for prognosis and treatment in patients with breast cancer. Imaging 1modalities such as ultrasound (US), MRI, CT, and 18F-FDG PET/CT are used for preoperative assessment. While conventional US is commonly recommended due to its resolution and sensitivity, it has limitations such as operator subjectivity and difficulty detecting small metastases. This review shows the microanatomy of axillary LNs to enhance accurate diagnosis and the characteristics of contrast-enhanced US (CE-US), which utilizes intravascular microbubble contrast agents, making it ideal for vascular imaging. A significant focus of this review is on distinguishing between two types of CE-US techniques for axillary LN evaluation: perfusion CE-US and lymphatic CE-US. Perfusion CE-US is used to assess LN metastasis via transvenous contrast agent administration, while lymphatic CE-US is used to identify sentinel LNs and diagnose LN metastasis through percutaneous contrast agent administration. This review also highlights the need for future research to clarify the distinction between studies involving “apparently enlarged LNs” and “clinical node-negative” cases in perfusion CE-US research. Such research standardization is essential to ensure accurate diagnostic performance in various clinical studies. Future studies should aim to standardize CE-US methods for improved LN metastasis diagnosis, not only in breast cancer but also across various malignancies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita, Akita, 010-8543, Japan. naokomori7127@gmail.com.
- Department of Diagnostic Radiology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-Machi, Aoba-Ku, Sendai, 980-8574, Japan.
- Department of Radiology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita, Akita, 010-8543, Japan.
- Department of Orthopaedic Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-Machi, Aoba-Ku, Sendai, 980-8575, Japan.
- Division of Image Statistics, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
Förderung
- Akita University
Zitieren
APA
Mori, N., Li, L., Matsuda, M., Mori, Y., & Mugikura, S. (2024). Prospects of perfusion contrast-enhanced ultrasound (CE-US) in diagnosing axillary lymph node metastases in breast cancer: a comparison with lymphatic CE-US. Journal of Medical Ultrasonics, 51(4), 587-597. https://doi.org/10.1007/s10396-024-01444-w
Vancouver
Mori N, Li L, Matsuda M, Mori Y, Mugikura S. Prospects of perfusion contrast-enhanced ultrasound (CE-US) in diagnosing axillary lymph node metastases in breast cancer: a comparison with lymphatic CE-US. Journal of Medical Ultrasonics. 2024;51(4):587-597. doi:10.1007/s10396-024-01444-w
BibTeX
@article{Mori2024,
author = {Mori, Naoko and Li, Li and Matsuda, Masazumi and Mori, Yu and Mugikura, Shunji},
title = {Prospects of perfusion contrast-enhanced ultrasound (CE-US) in diagnosing axillary lymph node metastases in breast cancer: a comparison with lymphatic CE-US},
journal = {Journal of Medical Ultrasonics},
year = {2024},
volume = {51},
number = {4},
pages = {587--597},
doi = {10.1007/s10396-024-01444-w}
}
EUVIMED